The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
KURA · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | KURA | ENOV | IBIO |
|---|---|---|---|
| Moat Score (0–100) | 32 (highest) | 32 (highest) | 32 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 50 (highest) | 50 (highest) | 20 |
| Pricing power | — | 68 | 70 (highest) |
| Returns on capital | 0 (highest) | 0 (highest) | 0 (highest) |
| Balance-sheet safety | 55 (highest) | 0 | 28 |
| Capital allocation | 24 | 44 (highest) | 44 (highest) |
| No price data | 48% above value if growth stopped today | No price data | |
| Market cap | $931M | $1.0B | $48.5M |
| Moat tier | No moat | No moat | No moat |
| Filing date | FY2025 | FY2025 | FY2026 |